S. Dimmeler et al., ANGIOTENSIN-II INDUCES APOPTOSIS OF HUMAN ENDOTHELIAL-CELLS - PROTECTIVE EFFECT OF NITRIC-OXIDE, Circulation research, 81(6), 1997, pp. 970-976
Angiotensin II (Ang II) importantly contributes to the pathobiology of
atherosclerosis. Since endothelial injury is a key event early in the
pathogenesis of atherosclerosis, we tested the hypothesis that Ang II
may injure endothelial cells by activation of cellular suicide pathwa
ys leading to apoptosis. Human umbilical venous endothelial cells (HUV
ECs) were incubated with increasing doses of Ang II for 18 hours. Apop
tosis of HUVECs was measured by ELISA specific for histone-associated
DNA fragments and confirmed by DNA laddering and nuclear staining. Ang
II dose-dependently induced apoptosis of HUVECs. Simultaneous blockad
e of both the AT(1) and AT(2) receptor prevented Ang II-induced apopto
sis, whereas each individual receptor blocker alone was not effective.
Selective agonistic stimulation of the AT(2) receptor also dose-depen
dently induced apoptosis. Ang II-mediated as well as selective AT(2) r
eceptor stimulation-mediated apoptosis was associated with the activat
ion of caspase-3, a central downstream effector of the caspase cascade
executing the cell death program. Specific inhibition of caspase-3 ac
tivity abrogated Ang II-induced apoptosis. In addition, the NO donors
sodium nitroprusside and S-nitrosopenicillamine completely inhibited A
ng II-induced apoptosis and eliminated caspase-3 activity. Thus, Ang I
I induces apoptosis of HUVECs via activation of the caspase cascade, t
he central downstream effector arm executing the cell death program. N
O completely abrogated Ang II-induced apoptosis by interfering with th
e activation of the caspase cascade.